USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NanoRETE, Inc
Address:
3815 Technology Blvd
Suite 1050
Lansing, MI
Phone:
N/A
URL:
EIN:
800712341
DUNS:
968162672
Number of Employees:
5
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $150,000.00 1
SBIR Phase II $750,000.00 1

Award List:

Development of a field-appropriate biosensor for detecting Mycobacterium tuberculosis infection

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$150,000.00
Agency:
DOD
Principal Investigator:
Finny Mathew, Sr. Research Scientist/PI – (616) 235-3567
Abstract:
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis (Mtb) that primarily affects the lungs. Approximately one third of the world"s population is latently infected with Mtb and at risk for developing active TB disease. Mtb grows slowly with visible growth appearing on solid media… More

Development of a field-appropriate biosensor for detecting Mycobacterium tuberculosis infection

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$750,000.00
Agency:
DOD
Principal Investigator:
Houng-Yau Mei, COO – (734) 649-2486
Abstract:
nanoRETE is a developing a nanoparticle-based biosensor technology platform that has the ability for real-time detection of pathogens. Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis (Mtb) that primarily affects the lungs. In Phase I research, nanoRETE demonstrated… More